A novel non-viral delivery method that enables efficient engineering of primary human T cells for ex vivo cell

Heather Kavanagh1, Susan Dunne1, Darren S Martin1

  • 1Avectas Ltd, Maynooth, Ireland.

Cytotherapy
|May 4, 2021
PubMed
Abstract

Related Concept Videos